SAN CARLOS, Calif., Jan. 15, 2021 /PRNewswire/ — Today, global diabetes nonprofit Beyond Type 1 celebrates the two year anniversary of the launch of Beyond Type 2 – a digital platform for those impacted by Type 2 diabetes, available in English and Spanish. Additionally, today marks the launch of a new way for people with Type 2 diabetes to connect – the Beyond Type 2 Community, a closed social network operated by the organization.
Beyond Type 2 is a program of diabetes nonprofit organization Beyond Type 1, providing a home online for those impacted by Type 2 diabetes. Beyond Type 2 operates parallel websites and social media channels in English and Spanish, with unique content tailored to each audience.
Since Beyond Type 2 launched in 2019, the web and social platforms have grown to serve a network of nearly half a million individuals impacted by Type 2 diabetes. Across English and Spanish platforms, Beyond Type 2’s resources, articles, and personal stories strive to provide readers the resources and support to manage and thrive with Type 2 diabetes.
Today’s launch of the Beyond Type 2 community – which also includes a Spanish-language section – provides another critical way for people with Type 2 diabetes to connect. The goal of the community, which can be accessed via web browser on desktop or via iOS or Android phone apps, is to provide a safe space online for anyone impacted by Type 2 diabetes (those who live with T2D or care for someone who does) to connect, troubleshoot, interact, and learn. If you or someone you love is impacted by Type 2 diabetes, request to join the community here.
Far too often, a Type 2 diabetes diagnosis carries shame and stigma. While Beyond Type 2 will continue to work to educate the general public, address misinformation and combat stigma related to Type 2 diabetes, this community needs dedicated spaces online – like the new Beyond Type 2 Community App – to connect.
“In the two years since launch, we’ve grown Beyond Type 2 into a rich, diverse resource and community for everyone impacted by Type 2 diabetes,” said Beyond Type 1 CEO Thom Scher. “The growth of the platform has been possible because of generous support from our Founding Partners; in 2021, we’re excited to be welcoming all of last year’s partners back and adding an additional partner focused on cardiovascular health.”
Beyond Type 2 is grateful for the continued support of Founding Partners Abbott (FreeStyle Libre 2), the Association of Diabetes Care & Education Specialists (ADCES), Lilly (Baqsimi), and Roche Diabetes Care (Accu-Chek®). Founding Partners were joined by Insulet (Omnipod) beginning in 2020 and Lilly (Trulicity) for 2021.
Beyond Type 2’s partners share the program’s vision of helping everyone impacted by Type 2 diabetes live well today.
Beyond Type 2 operates as a platform of registered 501(c)3 nonprofit organization Beyond Type 1, whose mission is to improve the lives of those living with diabetes.
Explore Beyond Type 2 at beyondtype2.org and Beyond Type 2 en Espanol at es.beyondtype2.org. Join the new Beyond Type 1 community at community.beyondtype2.org.
Media Contact
Kim Pace
kpace@lambert.com
About Beyond Type 1
Beyond Type 1 is a nonprofit organization changing what it means to live with diabetes. Through platforms, programs, resources, and grants, Beyond Type 1 is uniting the global diabetes community and providing solutions to improve lives today. Founded in 2015 with a focus on education, advocacy and the path to a cure for Type 1 diabetes, Beyond Type 1 has grown to also include programs for those with Type 2 diabetes. A new model of philanthropy, Beyond Type 1 aims to change what it means to live with chronic illness.
View original content:http://www.prnewswire.com/news-releases/beyond-type-2-celebrates-two-years-launches-new-community-platform-301209278.html
SOURCE Beyond Type 1
New findings support the company's neuroscience-driven approach to precision psychiatry, offering actionable insights for personalized…
Partnership will leverage Iktos's AI-enabled drug discovery platform and Cube Biotech's advanced protein technologies to…
SurVaxM is the first drug product to be produced in UI Pharmaceuticals new facilityUI Pharmaceuticals…
LAS VEGAS, Jan. 10, 2025 /PRNewswire/ -- RingConn, a leading smart wearable brand, is proud…
VANCOUVER, BC / ACCESSWIRE / January 10, 2025 / 1933 Industries Inc. (the "Company" or…
Montreal, Quebec--(Newsfile Corp. - January 10, 2025) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF)…